National Pharmaceutical Pricing Authority

Govt, private sector need to work in tandem for increasing healthcare affordability: Experts

The government and private players need to work together in the healthcare sector to increase the affordability of medical services as rising cost impacts access to patients, experts said

India rejects US request on price caps on medical devices as Centre aims to boost affordability of treatment

Price controls form part of PM Modi’s agenda to improve India’s dilapidated public health system and boost affordability of treatment.

Margins on drugs as high as 1,192% in four private hospitals: NPPA

Non-scheduled drugs and diagnostic services constituted major components of charges billed to patients in four private hospitals with margins as high as 1,192 percent, drug pricing regulator NPPA said on Tuesday

Govt's cheaper medicare drive pinches pharmaceutical sector, private hospitals in 2017

While the government's directive to doctors to prescribe only generic names unsettled pharma companies, the NPPA's (National Pharmaceutical Pricing Authority) move to cap prices of medical devices such as stents and knee implants created discomfort for the manufacturers.

NPPA sets deadline to lower prices of syringes and needles; manufacturers volunteer, set trade margin at 75%

Syringe and needle manufacturers set trade margins at maximum 75 percent in an attempt to self-regulate prices; NPPA sets deadline to 26 January

Gurugram child dies of dengue: NPPA says Fortis overcharged patient's family by margin as high as 1700%

Fortis hospital at Gurgaon charged as high as 1,700 percent margin on consumables and medicines used for the treatment of a dengue patient who subsequently died of the illness, the National Pharmaceutical Pricing Authority (NPPA) said

Drug price regulator caps prices of 51 essential formulations used for cancer, heart, skin treatment

NPPA fixes ceiling price of essential medicines of Schedule I under the Drugs (Prices Control) Order (DPCO) 2013

Donald Trump promises to reduce cost of prescription drugs in US, move may impact India

US president Donald Trump has promised to bring the cost of prescription drugs way down and let other countries pay more for these medicines in a new policy.

Abbott's decision to pull out Xience Alpine stent won't impact Indian patients, claim health activists

Abbott recently got the approval to withdraw Xience Alpine stent from India by the NPPA, however, health activists believe the move would benefit Indian high-end medical device makers

Knee implants price capped; saving to patients Rs 1,500 cr, says govt

NPPA has capped the price of widely used Cromium Cobalt knee implants at Rs 54,720 from earlier Rs 1.58-Rs 2.5 lakh